Navigation Links
Genomma Lab Internacional Revises 2009 Earnings Guidance
Date:9/8/2009

MEXICO CITY, Sept. 8 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), one of the fastest growing pharmaceutical and personal care products companies in Mexico with expansion into the international markets, announced today revisions to its earnings guidance for the full year of 2009. The Company expects net sales growth in the range of 35%-38% and an EBITDA margin of approximately 25%.

The revision of the Company's expected sales growth is mainly due to the higher sales anticipated from launches of the Company's recent acquisitions, namely Primer Nivel Por tu Salud(R), combined with a positive trend in demand for our base products in Mexico and in our existing international operations.

The Company is also slightly lowering its expected EBITDA margin due to the significant advertising investment required during the first months of a product launch. Once these launches stabilize, Genomma Lab expects their profitability margins to be in line with those of the rest of its portfolio.

It is important to highlight that this guidance revision is not contemplating sales from any geographic expansion of the Company's operations.

Genomma Lab will report third quarter results on October 26, 2009 and host a quarterly conference call the following business day.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Mexico with an increasing presence in the international markets. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. Through a combination of a successful new products development process, consumer-oriented marketing, a broad retail distribution network and a low- cost, highl
'/>"/>

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
2. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
3. Genomma Lab Internacional Acquires UNIGASTROZOL
4. Genomma Lab Announces 2009 Earnings Guidance
5. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
6. Genomma Lab Announces Initiation of Stock Repurchase Fund
7. Genomma Lab, New Participant in Market-Maker Program
8. Genomma Lab Announces Updated Fourth Quarter 2008 Guidance
9. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
10. Genomma Lab Internacional Announces Fourth Quarter and Full Year 2008 Results
11. Genomma Lab Acquires the Mexican Company Medicinas y Medicamentos Nacionales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Things, announces its latest addition to its screen mirroring and extending product line ... Extended Wireless Display, which operates in local WIFI setting, the new Splashtop Wired ...
(Date:9/2/2015)... ... ... Good health and a good cause paired up at The Barclays this past ... to the New Jersey Golf Foundation through its Healthy Steps Challenge. After making ... BCBSNJ challenged PGA TOUR golfer and NJ native Morgan Hoffmann to add more by ...
(Date:9/2/2015)... Laguna Beach, Calif. (PRWEB) , ... September 02, ... ... and injection therapy clinic combining both naturopathic and allopathic medicine, opens its second ... 92651. The new clinic features roughly 1000 square feet of lounge space for ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Cypress Benefit Administrators is taking action after seeing a significant increase in ... Argus Claim Review division has found many cases of OON ASCs encouraging members ...
(Date:9/2/2015)... ... September 02, 2015 , ... Amada Senior Care, premier provider of in-home care ... Johnson County location. Amada franchise partners Mike and Mell Fleming came to ... and spent over 20 years in medical device sales while Mell spent over 30 ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Amada Senior Care Expands to Greater Kansas City 2
... Offer Broader ChoiceEAGAN, Minn., April 13 Blue Cross ... the largest array of individual health plan options available ... insurance on their own. The new plans were designed ... "design your own health plan" sessions, in which prospective ...
... DETROIT, April 13 Metro Parent Publishing Group ... announce the second annual "Living with Autism Workshop" on ... event is designed to educate and empower locals about ... the general public will have the unique opportunity to ...
... The American Heart Association, with support from the ... research centers to study the development and mechanisms of ... four year, the centers will be conducting studies to ... improve outcomes for heart attack and heart failure patients.The ...
... nuts, and ,Mediterranean, fare most beneficial, researchers find ... nuts and the so-called "Mediterranean" diet are heart-friendly, ... glycemic index can harm your heart, say researchers ... 2007. , The studies included 146 prospective ...
... 5,000 years ago , , MONDAY, April 13 (HealthDay News) -- ... stomach,s sake," may have been heeded more than 5,000 years ... residues found in wine jars left in the tomb of ... had been steeped in herbs including balm, coriander, mint and ...
... of antidepressants makes little difference, study finds , , MONDAY, ... that people with heart disease caused by blockage of ... finds. , That finding was to be expected, said ... in Murray, Utah, and lead author of the study, ...
Cached Medicine News:Health News:Blue Cross Launches Largest Selection of Individual Plans Available in Minnesota 2Health News:Blue Cross Launches Largest Selection of Individual Plans Available in Minnesota 3Health News:Metro Parent's Second Annual 'Living With Autism Workshop' Features Local Experts Who Are Intimately Involved in Improving the Lives of These Special Children 2Health News:Three Medical Centers Awarded Funds to Study Generation of Cardiac Muscle Cells 2Health News:Review Confirms Links Between Diet, Heart Health 2Health News:Pharoah's Wine Jar Yields Medicinal Secrets 2Health News:Pharoah's Wine Jar Yields Medicinal Secrets 3Health News:Heart Disease and Depression Up Heart Failure Risk 2
(Date:9/2/2015)... -- Kastle Therapeutics (Kastle), a biopharmaceutical company focused on ... high unmet medical needs, announced today that it ... positions. Sean McAuliffe has ... Global Marketing Director for Baxalta. Nick Smith ... and Analytics; Nick was previously Director, Forecasting and ...
(Date:9/2/2015)... Ascletis announced today the completion of a US$35 million ... C-Bridge Capital, joined by Tasly Pharmaceutical and ... Company before financing was US$300 million. The ... Ascletis, pipeline, strengthen global development capabilities and enhance GMP ... investors, Ascletis is now entering an exciting new era. ...
(Date:9/2/2015)... , Sept. 2, 2015   Voalte , ... new capital infusion of $17 million by Ascension ... Corporation, and Bedford Funding. Series D funding closed on ... raised to nearly $60 million in three years. ... a triple-digit growth trajectory for Voalte. The privately held ...
Breaking Medicine Technology:Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3Ascletis Secures US$35 Million Financing 2Ascletis Secures US$35 Million Financing 3Voalte Raises $17 Million in Series D Financing 2Voalte Raises $17 Million in Series D Financing 3Voalte Raises $17 Million in Series D Financing 4
... Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- ... and,pharmacokinetic profiles of Basilea's (SWX:BSLN) two late-stage,drug ... ceftobiprole, the first anti-MRSA broad-spectrum,cephalosporin in late-stage ... the treatment of invasive fungal infections,yielded further ...
... 4, 2007 - CytRx Corporation,(NASDAQ:CYTR) today announced ... that CytRx's lead drug candidate,arimoclomol significantly accelerated ... an experimental rat model of stroke, even ... hours after stroke was,induced. These data confirm ...
Cached Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 3CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 4CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 5
Stryker Endoscopy offers a superior selection of probes and tips that interface with our suction and irrigation system....
The new PERIMOUNT Magna heart valve (bioprosthesis), with its true supra-annular design, offers optimal hemodynamics and flow characteristics for treatment of aortic heart valve disease....
... revolutionary flexibility to floor-mounted X-ray systems. ... move the C-arm around the exam ... optimal angle for cardiac and general ... cardiac flat panel detector that delivers ...
... pH.p Capsule passes through the GI tract, it ... frequencies to the SmartPill Data Receiver, a small, ... the patient (supported by either a belt or ... and pH measurement data, and elapsed and real ...
Medicine Products: